Abstract

The Notch pathway is a highly conserved juxtacrine signaling mechanism that is important for many cellular processes during development, including differentiation and proliferation. Although Notch is important during ovarian follicle formation and early development, its functions during the gonadotropin-dependent stages of follicle development are largely unexplored. We observed positive regulation of Notch activity and expression of Notch ligands and receptors following activation of the luteinizing hormone-receptor in prepubertal mouse ovary. JAG1, the most abundantly expressed Notch ligand in mouse ovary, revealed a striking shift in localization from oocytes to somatic cells following hormone stimulation. Using primary cultures of granulosa cells, we investigated the functions of Jag1 using small interfering RNA knockdown. The loss of JAG1 led to suppression of granulosa cell differentiation as marked by reduced expression of enzymes and factors involved in steroid biosynthesis, and in steroid secretion. Jag1 knockdown also resulted in enhanced cell proliferation. These phenotypes were replicated, although less robustly, following knockdown of the obligate canonical Notch transcription factor RBPJ. Intracellular signaling analysis revealed increased activation of the mitogenic phosphatidylinositol 3-kinase/protein kinase B and mitogen-activated protein kinase/extracellular signal-regulated kinase pathways following Notch knockdown, with a mitogen-activated protein kinase kinase inhibitor blocking the enhanced proliferation observed in Jag1 knockdown granulosa cells. Activation of YB-1, a known regulator of granulosa cell differentiation genes, was suppressed by Jag1 knockdown. Overall, this study reveals a role of Notch signaling in promoting the differentiation of preovulatory granulosa cells, adding to the diverse functions of Notch in the mammalian ovary.

As key structural and functional units of the female gonad, ovarian follicles are responsible for the growth and ovulation of high-quality oocytes that ensure fertility, as well as for the production of steroid and peptide hormones important for reproductive physiology. The formation, growth, and function of these follicles are controlled by networks of intraovarian and endocrine signals. Local factors, acting through paracrine and juxtacrine mechanisms, are important for follicle formation and early development to the secondary follicle stage. These include, but are not limited to, estrogen (1–3), progesterone (4), Kit/Kit-ligand (5, 6), the transforming growth factor β superfamily (7–9), and the Notch signaling pathway (10–12). Following puberty and activation of the hypothalamic-pituitary-gonadal axis, follicle-stimulating hormone (FSH) from the pituitary drives follicular maturation through regulation of granulosa cell proliferation and differentiation (13). In response to FSH and activin signaling, rapid follicular growth is achieved through increased expression of cyclin D2 (Ccnd2) (14). FSH also induces gene expression changes in granulosa cells to make them responsive to the midcycle ovulatory luteinizing hormone (LH) surge (13). Hallmarks of these differentiating granulosa cells include increasing production of estrogen and progesterone through elevated expression of the rate-limiting enzymes in their biosynthesis Cyp19a1 and Cyp11a1, as well as expression of the membrane receptor for LH (Lhcgr) (13).

The highly conserved Notch signaling pathway is emerging as an important means of intrafollicular communication. As a cell contact-dependent pathway, Notch signaling requires binding of membrane bound Notch receptors to membrane-bound Jagged or Delta-like ligands on adjacent cells (15). This ligand-receptor interaction leads to a proteolytic cleavage cascade that ultimately liberates the Notch intracellular domain (NICD) of the receptor through action of the γ-secretase complex (16). NICD translocates to the nucleus and acts as a transcriptional activator following binding with the obligate cofactor RBPJκ (17). During development, activation of Notch signaling leads to pleiotropic effects, which include cell proliferation, specification, and differentiation, impacting organ formation and patterning (18).

The involvement of Notch signaling in follicles and granulosa cells has been demonstrated through pharmacological and genetic means in various culture and mouse models. Initial interest in Notch signaling in the ovary came from efforts to understand the molecular mechanisms behind the formation of primordial follicles, where pregranulosa cells interact closely with clusters of cytoplasmically connected oocytes, termed germ cell nests or syncitia, and eventually encapsulate a single germ cell within each follicle (19). Disruption of Notch signaling using the γ-secretase inhibitor, N-(N-(3,5-difluorophenacetyl)-l-alanyl)-S-phenylglycine t-butyl ester (DAPT), in cultured neonatal ovaries results in retention of germ cells in nests and reduced numbers of primordial follicles (10–12). Conditional knockout in mice of Notch2 in granulosa cells and Jag1 in oocytes results in formation of multioocytic follicles, which are postulated to be the result of incomplete germ cell nest breakdown, and these mice exhibit reduced fertility (11, 12). Characterization of infertile mice with a null mutation in the Notch receptor modifier Lunatic fringe (lfng) also reveals defects in follicle development and meiotic maturation of the ovulated oocyte (20), whereas an independently derived Lfng–/– mouse line is subfertile (21). Disruption of Hes1, a Notch target/effector gene (22), was shown to result in a decreased proportion of oocytes progressing to meiosis I, reduced oocyte survival following germ cell nest breakdown, and subsequent impaired fertility (23). Although various genetic models of ovarian Notch disruption present with reduced fertility or infertility, analysis of ovarian phenotypes has largely focused on follicle formation and early follicle growth and development (11, 20, 23).

Notch signaling molecules and effector genes have been shown to be expressed in gonadotropin-responsive follicles; however, their roles during later stages of follicle development are largely unexplored (24, 25). Gonadotropin interactions with underlying local signals are critical for control of follicular functions, including growth and differentiation (26). To better understand the dynamics of ovarian Notch signaling during the gonadotropin-dependent stages of follicle development, we used a Notch-responsive transgenic reporter mouse line to identify Notch activity in granulosa cells of all stages of follicular growth as well as in luteal cells. We found that Notch activity in the ovary is upregulated following activation of LHCGR by exogenous human chorionic gonadotropin (hCG). This net-positive regulation of Notch activity was accompanied by similarly increased expression of Notch2 and Jag1 following hCG stimulation. Although the ligand JAG1 was previously thought to be germ cell restricted, we found that JAG1 expression shifts to multiple types of steroidogenically active somatic cells following hormone stimulation. Using cultured primary granulosa cells, we identified a role for Jag1, through canonical Notch signaling, in regulating differentiation and proliferation of these cells. Together, these experiments demonstrate that, consistent with its known role in development, Notch signaling regulates the balance between differentiation and proliferation in ovarian granulosa cells.

Materials and Methods

Animal treatments and tissue collection

CD1 mice (Charles River Laboratories, Wilmington, MA) were maintained on a 12-hour light/dark cycle in controlled environmental condition with access to water and food ad libitum. A diet free from alfalfa and soybean was used to minimize levels of naturally occurring phytoestrogens (2919 for breeding pairs, 2916 for maintenance; Teklad Diets, Harlan, Madison, WI). The transgenic Notch responsive (TNR) EGFP reporter mice (27) were a generous gift from Nicholas Gaiano (Johns Hopkins University, Baltimore, MD) and were maintained on a CD1 background.

For hormone treatment, prepubertal postnatal day (PND) 19 CD1 mice were given an intraperitoneal (IP) injection of 5 IU pregnant mare’s serum gonadotropin (PMSG; Sigma Aldrich, St. Louis, MO) and, after 48 hours, were either euthanized or given an IP injection of 5 IU hCG (Sigma Aldrich, St. Louis, MO). Animals were euthanized at various time points following hCG as indicated in the “Results” section. All animal protocols were approved by the Institutional Animal Care and Use Committee of Northwestern University (Evanston, IL).

Immunologic detection on histological samples

Ovarian tissue samples were dissected in phosphate buffer saline and fixed overnight in 4% paraformaldehyde in phosphate buffer saline at 4°C. Samples were embedded in paraffin and sectioned at 5 μm for histological analysis. Immunohistochemistry (IHC), and immunofluorescence (IF), were performed as previously described (10). Primary antibodies used include a goat polyclonal anti-JAG1 (SC-6011; Santa Cruz Biotechnology, Dallas, TX), a rabbit monoclonal anti-P450SCC (14217; Cell Signaling Technology, Danvers, MA), and a rabbit polyclonal anti-GFP (A11122; Life Technology, Eugene, OR). Biotinylated conjugated secondary antibodies against goat (BA-5000) or rabbit (BA-1000) were purchased from Vector Laboratories (Burlingame, CA) and used with a Colorimetric Tyramide Signal Amplification kit (for GFP IHC; PerkinElmer, Waltham, MA) or a VECTASTAIN Elite ABC Kit (Vector Laboratories). Methyl green or 4′,6-diamidino-2-phenylindole were used as counterstains, as appropriate.

RNA isolation and quantitative real-time polymerase chain reaction

Ovaries were dissected, and the bursae were removed. Samples were immediately preserved in RNAlater reagent (Invitrogen, Carlsbad, CA) overnight at 4°C and then stored at –80°C prior to RNA extractions. Total RNA was extracted using RNeasy Plus Mini Kit (QIAGEN, Valencia, CA). For cultured granulosa cells, total RNA was extracted using Quick-RNA MicroPrep (Zymo Research, Irvine, CA). RNA was reverse transcribed to complementary DNA using SuperScript IV First-Strand Synthesis System (Invitrogen). Quantitative real-time polymerase chain reaction (qRT-PCR) assays were performed using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) using either an Applied Biosystems 7300 (Applied Biosystems) or BioRad CFX384 (Bio-Rad Laboratories, Hercules, CA) thermocycler. The comparative cycle threshold (28) method was used for relative quantification using Rpl19 (29) as an internal control. The sequences of primers used for qRT-PCR are provided in Supplemental Table 1.

Primary granulosa cell culture and small interfering RNA knockdown

PND21 mice were given IP injection of 5 IU PMSG for 48 hours. Granulosa cells were collected by follicle puncture and cultured as previously described (30). Oocytes were removed with a 40-μm cell strainer (Fisher Scientific, Hampton, NH). Granulosa cells were cultured at 175,000 cells/well in 24-well plates in a humidified incubator at 37°C and 5% CO2 using a 1:1 ratio of Dulbecco’s modified Eagle medium:F-12 medium (Fisher Scientific) supplemented with 15 mM HEPES, pH 7.4, 5 mg/mL transferrin, 2 mg/mL insulin, 40 ng/mL hydrocortisone, 10% fetal bovine serum, and 100 U/mL penicillin/streptomycin (4F media). Cells were allowed to adhere and to reach 90% confluency for 96 hours prior to small interfering RNA (siRNA) transfection. siGENOME SMARTpool (GE Dharmacon, Lafayette, CO) was used at concentrations of 20 nM (siJag1, siScramble) or 40 nM (siRbpj, siScramble). siRNA transfection was done using DharmaFect I reagent (GE Dharmacon) in 4F media supplemented with 10% charcoal-stripped fetal bovine serum. RNA or protein was extracted 72 hours after transfection. The mitogen-activated protein kinase kinase (MEK) inhibitor PD98059 (513000; Calbiochem, San Diego, CA) was added at a concentration of 4 μM, 24 hours following siRNA transfection for a total incubation time of 48 hours. The protein kinase B (AKT) inhibitor MK2206 (S1078; Selleck Chemicals, Houston, TX) was added at a concentration of 10 nM, 24 hours following siRNA transfection for a total incubation time of 48 hours.

Protein extraction and western blotting

Cells were lysed with ice-cold radioimmunoprecipitation assay buffer supplemented with 10 μg/mL aprotinin, 10 μg/mL leupeptin, 1 μg/mL pepstatin, 1 mM phenylmethylsulfonyl fluoride, 1 μg/mL antipain, and 20 U/mL benzonase nuclease (Sigma Aldrich) with freshly added Phosphatase Inhibitor Cocktail 2 (1% volume-to-volume ratio, Sigma Aldrich) and Phosphatase Inhibitor Cocktail 3 (1% volume-to-volume ratio, Sigma Aldrich). Ten micromolar of forskolin was added 1 hour prior to lysate collection. Total protein was measured by bicinchoninic assay (Thermo Fisher Scientific, Waltham, MA). Equal amounts of protein were separated on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels and blotted onto nitrocellulose membranes. Membranes were incubated overnight at 4°C in primary antibody and for 1 hour at room temperature with infrared dye conjugated secondary antibody. In addition to the antibodies listed previously, primary antibodies used include a rabbit polyclonal anti-RBPJ (25949; Abcam, Cambridge, MA), a rat monoclonal anti-NOTCH2 (C651.6DbHN; Developmental Studies Hybridoma Bank, Iowa City, IA), a rabbit monoclonal anti-GAPDH (2118; Cell Signaling Technology), a rabbit monoclonal anti-panAKT (4691; Cell Signaling Technology), a rabbit monoclonal anti-ERK1/2 (4695; Cell Signaling Technology), a rabbit monoclonal anti-phospho-AKT (Ser473, 4060; Cell Signaling Technology), a rabbit polyclonal anti-phospho-ERK1/2(Thr202/Tyr204, 9101; Cell Signaling Technology), a rabbit polyclonal anti-phospho-FOXO1 (Ser256, 9461; Cell Signaling Technology), a rabbit monoclonal anti-FOXO1 (2880; Cell Signaling Technology), a rabbit monoclonal anti-phospho-YB1 (Ser102, 2900; Cell Signaling Technology), and a rabbit monoclonal anti-YB1 (8475; Cell Signaling Technology). Infrared (IR) dye conjugated secondary antibodies were purchased from LI-COR Biosciences (IRDye 800CW Goat anti-Rabbit IgG 925-32211, IRDye 680RD Donkey anti-Rabbit IgG 926-68073, IRDye 800CW Donkey anti-Goat IgG 925-32214, IRDye 800CW Goat anti-Rat IgG 926-32219, IRDye 680RD Goat anti-Rat IgG 926-68076; Lincoln, NE). Membranes were washed and fluorescence signals were detected using a Syngene PXi multiapplication gel imaging system equipped with Epi LED illumination for infrared detection (Syngene, Frederick, MD).

Flow cytometry analysis for cell proliferation and apoptosis

Primary granulosa cells were cultured and transfected with siRNA as described previously. For proliferation and apoptosis analyses, cells were cultured at 875,000 cells/well in a six-well plate for 96 hours. Cells were then transfected with siRNA for 24 hours, after which they were trypsinized and replated in 24-well plates at subconfluent density of 175,000 cells/well. For apoptosis analysis, cells were harvested 48 hours after replating (72 hours post transfection) and processed for Annexin V and propidium iodide (PI) staining with a Dead Cell Apoptosis Kit with Annexin V Alexa Fluor 488 and PI (Invitrogen). For proliferation assays, 5-ethynyl-2′-deoxyuridine (EdU) was added to the culture media at a concentration of 10 μM 6 hours prior to cell harvest and at 42 hours following replating. A Click-iT EdU Alexa Fluor 647 Flow Cytometry kit was used for EdU detection (Invitrogen). Labeled cells were analyzed in a BD FACSAria II (BD Biosciences, San Jose, CA).

Estradiol-17β and progesterone enzyme-linked immunosorbent assay

Granulosa cells were cultured and transfected with siRNA as described previously in charcoal-stripped serum. At the end of culture, media was collected. Estradiol-17β (E2) levels were measured in undiluted media using an estradiol human enzyme-linked immunosorbent assay (ELISA; ALPCO, Salem, NH) with a range of detection of 10 to 1000 pg/mL. The intra-assay coefficient of variation (CV%) was 6.3 and the interassay CV% was 8.1. Progesterone (P4) levels were measured in 1:100 diluted media using P4 mouse and rat ELISA with a range of detection of 0.15 to 40 ng/mL (IBL, Minneapolis, MN). The intra-assay CV% was 3.9 and the interassay CV% was 9.0 for this assay. All hormone measurement was conducted at the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core.

Statistical analysis

Data are presented as means ± standard error of the mean. Experiments were performed using a minimum of three biological replicates and control groups, as stated. Differences between groups were calculated with GraphPad Prism (GraphPad Software, Inc, La Jolla, CA) using a Student t test or analysis of variance with Tukey post hoc, as appropriate. Differences were considered to be significant at a 95% confidence interval (P < 0.05).

Results

Identification of Notch active cells in unstimulated and gonadotropin-treated ovaries

To investigate the localization of Notch active cells in the prepubertal ovary (PND19), we used the TNR reporter line that we had used previously to identify Notch active cells during ovarian follicle formation (12). Using IHC to detect the EGFP reporter, we observed that granulosa cells of growing follicles of various stages stained positively for EGFP, indicating that Notch signaling is active throughout follicular development (Fig. 1A and 1B). Of note, Notch activity was detected in antral follicles, a population of follicles in which continued growth and development will depend on pituitary gonadotropins (31). Because Notch signaling has been previously shown to regulate granulosa cells function (32), and gonadotropins are known to exert their functions through interactions with local signals within the ovary, these observations led us to investigate potential gonadotropin regulation of ovarian Notch activity.

The transgenic Notch reporter shows activity and is dynamically regulated in gonadotropin-stimulated mouse ovaries. (A, B) In the prepubertal PND19 ovary, EGFP from the Notch reporter line was detected using IHC in granulosa cells of the growing follicle population, including late secondary and early antral follicles. Prepubertal animals were stimulated with PMSG to stimulate follicle growth, followed by hCG 48 hours later to stimulate ovulation. (C) Egfp expression was quantified using qRT-PCR in samples collected at different time points. Data are presented as values relative to Rpl19 and normalized to the unstimulated PND19 samples. Egfp expression was significantly upregulated 24 hours following hCG as compared with the unstimulated control. n = 5; *P < 0.05 compared with unstimulated (Unst). (D, E) Following hCG treatment (24 hours post hCG), Notch activity was detected in corpora lutea (CL) with some staining within the stroma. (F, G) In the luteinized ovary (3 days post hCG), Notch activity remained in CL and granulosa cells of antral follicles (AntF). Scale bars = 100 μm.
Figure 1.

The transgenic Notch reporter shows activity and is dynamically regulated in gonadotropin-stimulated mouse ovaries. (A, B) In the prepubertal PND19 ovary, EGFP from the Notch reporter line was detected using IHC in granulosa cells of the growing follicle population, including late secondary and early antral follicles. Prepubertal animals were stimulated with PMSG to stimulate follicle growth, followed by hCG 48 hours later to stimulate ovulation. (C) Egfp expression was quantified using qRT-PCR in samples collected at different time points. Data are presented as values relative to Rpl19 and normalized to the unstimulated PND19 samples. Egfp expression was significantly upregulated 24 hours following hCG as compared with the unstimulated control. n = 5; *P < 0.05 compared with unstimulated (Unst). (D, E) Following hCG treatment (24 hours post hCG), Notch activity was detected in corpora lutea (CL) with some staining within the stroma. (F, G) In the luteinized ovary (3 days post hCG), Notch activity remained in CL and granulosa cells of antral follicles (AntF). Scale bars = 100 μm.

To determine whether Notch activity changes in the ovary following activation of follicle-stimulating hormone receptor (FSHR) and LHCGR, we quantified the Egfp reporter expression using qRT-PCR. Samples were collected at 48 hours post PMSG treatment and at various time points following hCG treatment. These time points were selected to capture the preovulatory state, the highly dynamic ovulatory cascade, and subsequent luteinization. Expression of the Egfp reporter was measured relative to that in PND19 unstimulated ovaries. As shown in Fig. 1C, Egfp expression was unchanged following PMSG stimulation, but was significantly upregulated by 24 hours post hCG.

We proceeded to identify the Notch active cells in luteinized ovaries by using IHC for the TNR EGFP reporter in sections from 24-hour and 3-day post-hCG ovaries (Fig. 1D–1G). Corpora lutea (CL) in these sections stained positively for EGFP, indicating that Notch activity remains following ovulation of the follicle and the loss of the oocyte. Although there appears to be some EGFP staining in the stroma at 24 hours post hCG (Fig. 1D and 1E), EGFP staining in the 3-day post-hCG ovary was restricted to follicular and CL boundaries. (Fig. 1F and 1G). These findings suggest that Notch signaling is dynamically regulated by hCG in the ovary during the periovulatory period.

Expression and localization of Notch signaling molecules in the ovary following hormone stimulation

Having observed regulation of the TNR reporter by hCG, we characterized gene expression of the four Notch receptors and five Jagged and Delta-like ligands in ovaries following exogenous gonadotropin stimulation (Fig. 2; Supplemental Fig. 1). We focused on the expression of the ligands Jag1 and Jag2, as well as the receptors Notch2 and Notch3, as we previously found these ligands and receptors to be the most abundantly expressed in neonatal ovaries (12) and they have also been previously reported to be expressed in adult cycling ovaries (24, 25). Compared with unstimulated ovaries, expression of Notch signaling molecules did not change following PMSG treatment. By contrast, hCG exerts positive regulation on all Notch receptors and ligands, with the exception of Jag2, although the timing of the upregulation observed is transcript specific.

Expression of Notch ligands and receptors is positively regulated by gonadotropins. Expression of Jag1, Jag2, Notch2, and Notch3 were quantified using qRT-PCR in samples collected after 48 hours of PMSG stimulation, followed by hCG stimulation for the times indicated. Data are presented as relative to Rpl19. Compared with unstimulated PND19 ovaries, Jag1 and Notch2 expression was transiently upregulated 4 to 12 hours post hCG stimulation. n = 10 for unstimulated samples, n = 5 for PMSG- and hCG-stimulated samples; *P < 0.05 compared with unstimulated. Modest upregulation of Notch3 was seen in luteinized ovaries (3 and 6 days post hCG), whereas Jag2 remained unchanged following exogenous gonadotropin stimulation.
Figure 2.

Expression of Notch ligands and receptors is positively regulated by gonadotropins. Expression of Jag1, Jag2, Notch2, and Notch3 were quantified using qRT-PCR in samples collected after 48 hours of PMSG stimulation, followed by hCG stimulation for the times indicated. Data are presented as relative to Rpl19. Compared with unstimulated PND19 ovaries, Jag1 and Notch2 expression was transiently upregulated 4 to 12 hours post hCG stimulation. n = 10 for unstimulated samples, n = 5 for PMSG- and hCG-stimulated samples; *P < 0.05 compared with unstimulated. Modest upregulation of Notch3 was seen in luteinized ovaries (3 and 6 days post hCG), whereas Jag2 remained unchanged following exogenous gonadotropin stimulation.

The regulation by hCG of Jag1 messenger RNA (mRNA) was surprising, given the previously reported localization of JAG1 protein expression to the oocyte (10, 12, 24). This led us to further characterize ovarian JAG1 localization following gonadotropin stimulation of PND19 mice (Fig. 3). Following PMSG stimulation, JAG1 was localized predominantly to oocytes of preovulatory follicles (Fig. 3A). Limited expression was also detected in somatic cells (Fig. 3A). However, within 12 hours post hCG treatment, JAG1 staining could be robustly detected within somatic cells of periovulatory follicles, the thecal layer, and a subset of interstitial cells (Fig. 3B). By 24 hours and 3 days post hCG treatment, JAG1 staining was detected in CL (Fig. 3C and 3D).

JAG1 is localized to steroidogenically active somatic cells following hormone stimulation. JAG1 localization was detected using IF in (A) 48-hour post-PMSG, (B) 12-hour post-hCG, (C) 24-hour post-hCG, and (D) 3-day post-hCG ovarian sections. (A) In the PMSG 48-hour ovary, JAG1 was detected in oocytes (Oo; arrow) with some weaker signals in somatic cells. (E–H) Following hCG stimulation, JAG1 signals in somatic cells became more robust and localized to steroidogenically active structures as marked by P450 side-chain cleavage staining. Most notably, JAG1 was detected in thecal interstitial cells (Int; arrow) and CL (arrow). Scale bars = 100 μm.
Figure 3.

JAG1 is localized to steroidogenically active somatic cells following hormone stimulation. JAG1 localization was detected using IF in (A) 48-hour post-PMSG, (B) 12-hour post-hCG, (C) 24-hour post-hCG, and (D) 3-day post-hCG ovarian sections. (A) In the PMSG 48-hour ovary, JAG1 was detected in oocytes (Oo; arrow) with some weaker signals in somatic cells. (E–H) Following hCG stimulation, JAG1 signals in somatic cells became more robust and localized to steroidogenically active structures as marked by P450 side-chain cleavage staining. Most notably, JAG1 was detected in thecal interstitial cells (Int; arrow) and CL (arrow). Scale bars = 100 μm.

To gain additional insights into the identity of the JAG1-expressing somatic cells following hormone stimulation, we probed consecutive ovarian sections from PMSG- and hCG-stimulated mice for the P450 side-chain cleavage (P450SCC) enzyme to mark steroid-producing cells (Fig. 3E–3H). Indeed, following hormone stimulation, JAG1 was localized to the same cell types that are marked by P450SCC staining. Most readily discernable in hCG 24-hour (Fig. 3C and 3G) and hCG 3-day (Fig. 3D and 3H) ovarian sections, JAG1 became localized to steroidogenically active thecal and thecal-interstitial cells, as well as CLs, following hCG stimulation.

Steroid biosynthesis and proliferation in cultured primary granulosa cells

To better understand the potential functions for JAG1 in somatic cells during the gonadotropin-dependent stages of follicular development, we turned to primary cultures of mouse granulosa cells, a model extensively used to study gene function and gain mechanistic insights into the signaling pathways that regulate granulosa cell and follicular activities. Overtime, these cells are known to spontaneously differentiate under appropriate culture conditions (33). Most importantly for this study, these primary granulosa cells continue to express Notch ligands and receptors as detected by mRNA (Fig. 4A). The most abundantly expressed ligand and receptor, JAG1 and NOTCH2, are shown in western blot in Fig. 4B. JAG1 levels decrease beginning at day 5 of culture, whereas NOTCH2 levels show a modest transient upregulation at day 5 of culture (Fig. 4C).

Notch ligands and receptors are expressed in cultured granulosa cells. Jag1 and Notch3 expression were found to be dynamically regulated throughout 7 days of granulosa cell culture. (A) Jag1 expression peaks at 3-day culture, whereas Notch3 expression continues to rise as the culture progresses. n = 3; *P ≤ 0.05 compared with 1-day culture. (B) The presence of JAG1 and NOTCH2 were confirmed using western blot. (C) Quantification of the western blot shows JAG1 levels decrease throughout the culture period beginning at day 5, whereas NOTCH2 levels transiently peak at day 5 of culture. n = 3, *P < 0.05 compared with 1-day culture.
Figure 4.

Notch ligands and receptors are expressed in cultured granulosa cells. Jag1 and Notch3 expression were found to be dynamically regulated throughout 7 days of granulosa cell culture. (A) Jag1 expression peaks at 3-day culture, whereas Notch3 expression continues to rise as the culture progresses. n = 3; *P ≤ 0.05 compared with 1-day culture. (B) The presence of JAG1 and NOTCH2 were confirmed using western blot. (C) Quantification of the western blot shows JAG1 levels decrease throughout the culture period beginning at day 5, whereas NOTCH2 levels transiently peak at day 5 of culture. n = 3, *P < 0.05 compared with 1-day culture.

Figure 5A and 5B illustrates that primary granulosa cells cultured from PMSG-primed mouse ovaries exhibit characteristics of differentiating granulosa cells. These granulosa cells secrete E2 and P4 through increasing expression of the Star, Cyp19a1, and Cyp11a1 genes (34). The level of steroidogenic activity was increased as the culture period progressed. At the initiation of culture, these cells were proliferative, but the rate of proliferation decreased with time in culture, as they both differentiate and eventually become contact inhibited (Fig. 5C).

PMSG-primed primary granulosa cells differentiate in culture. (A) Primary granulosa cells secrete estradiol and P4 throughout the 7-day culture period. The levels of E2 and P4 in the culture medium steadily increase throughout the culture period. (B) The increase in hormone production is consistent with increasing expression of Star, Cyp19a1, and Cyp11a1. (C) Primary granulosa cells are proliferative in culture as identified using an EdU incorporation assay. This proliferative potential diminishes as the culture progresses, and cells eventually become contact inhibited (data not shown). n = 3; *P < 0.05 compared with 1-day culture unless otherwise indicated.
Figure 5.

PMSG-primed primary granulosa cells differentiate in culture. (A) Primary granulosa cells secrete estradiol and P4 throughout the 7-day culture period. The levels of E2 and P4 in the culture medium steadily increase throughout the culture period. (B) The increase in hormone production is consistent with increasing expression of Star, Cyp19a1, and Cyp11a1. (C) Primary granulosa cells are proliferative in culture as identified using an EdU incorporation assay. This proliferative potential diminishes as the culture progresses, and cells eventually become contact inhibited (data not shown). n = 3; *P < 0.05 compared with 1-day culture unless otherwise indicated.

Characterization of steroidogenesis following Jag1 or Rbpj knockdown in cultured primary granulosa cells

To study the function of JAG1 in steroidogenically active granulosa cells, we used siRNA to knock down its expression. We also conducted a similar siRNA experiment targeting the obligatory transcriptional cofactor for canonical Notch signaling, Rbpj (15). siJag1 and siRbpj efficiently and specifically reduced mRNA and protein levels of their respective targets (Fig. 6A; Supplemental Fig. 2). mRNA measurements revealed reduced expression of genes encoding several of the factors and enzymes involved in steroid biosynthesis following Jag1 and Rbpj knockdown (Fig. 6B), including Star, Cyp19a1, and Cyp11a1. Confirming the gene expression findings, levels of E2 were significantly reduced in the culture medium of both Jag1 and Rbpj knockdown cells (Fig. 6C and 6D) 72 hours post transfection (a total of 7 days of culture). P4 levels, however, were found to be significantly reduced only in the Jag1 knockdown cell cultures (Fig. 6D).

Steroid biosynthesis is suppressed following Jag1 and Rbpj knockdown in cultured granulosa cells. (A) The Notch ligand JAG1 and the canonical Notch signaling transcriptional cofactor RBPJ were efficiently and specifically decreased following siRNA transfection. (B) Expression of factors and enzymes involved in the steroid biosynthetic cascade was downregulated following Jag1 and Rbpj knockdown. The dashed line indicates the level of expression in siScramble samples. (C) Jag1 knockdown results in decreased levels of E2 and P4 in culture media. (D) Consistent with the less robust knockdown of Rbpj, only E2 levels were found to be significantly decreased in siRbpj samples. n = 3; *P < 0.05 compared with siScramble.
Figure 6.

Steroid biosynthesis is suppressed following Jag1 and Rbpj knockdown in cultured granulosa cells. (A) The Notch ligand JAG1 and the canonical Notch signaling transcriptional cofactor RBPJ were efficiently and specifically decreased following siRNA transfection. (B) Expression of factors and enzymes involved in the steroid biosynthetic cascade was downregulated following Jag1 and Rbpj knockdown. The dashed line indicates the level of expression in siScramble samples. (C) Jag1 knockdown results in decreased levels of E2 and P4 in culture media. (D) Consistent with the less robust knockdown of Rbpj, only E2 levels were found to be significantly decreased in siRbpj samples. n = 3; *P < 0.05 compared with siScramble.

Proliferation and apoptosis in cultured primary granulosa cells following Jag1 or Rbpj knockdown

To ensure that the reduced levels of E2 and P4 in granulosa cell culture media following disruption of Notch signaling are not a consequence of compromised cell survival, and thus reduced cell number, we characterized apoptosis and cell death. Annexin V was used to label early apoptotic cells, whereas PI exclusion was used to measure dead cells. Our results showed that the percentage of dead cells (Annexin+/PI+) in siJag1 and siRbpj samples was not changed compared with the nontargeting siScramble (Fig. 7A and 7B). Surprisingly, knockdown of Jag1 or Rbpj resulted in fewer granulosa cells undergoing apoptosis (Fig. 7A and 7B).

Knockdown of Jag1 and Rbpj in cultured granulosa cells results in the retention of proliferative potential. Apoptosis and proliferation assays were done 3 days following siRNA transfection, with a total culture period of 7 days. (A, B) As measured by Annexin V staining and PI exclusion assay, Jag1 or Rbpj knockdown did not result in increased cell death. Instead, Jag1 and Rbpj knockdown led to decreased cellular apoptosis. (C, D) An increased rate of cell proliferation was observed following Jag1 and Rbpj knockdown. n = 3; *P < 0.05 compared with siScramble.
Figure 7.

Knockdown of Jag1 and Rbpj in cultured granulosa cells results in the retention of proliferative potential. Apoptosis and proliferation assays were done 3 days following siRNA transfection, with a total culture period of 7 days. (A, B) As measured by Annexin V staining and PI exclusion assay, Jag1 or Rbpj knockdown did not result in increased cell death. Instead, Jag1 and Rbpj knockdown led to decreased cellular apoptosis. (C, D) An increased rate of cell proliferation was observed following Jag1 and Rbpj knockdown. n = 3; *P < 0.05 compared with siScramble.

As shown previously (Fig. 5), PMSG-primed primary granulosa cells exhibited hallmarks of differentiation, as they became highly steroidogenic and exited the cell cycle as the culture progressed. Suppression of steroidogenesis following Notch pathway knockdown suggests an impact on this differentiation process. To test whether cell proliferation is likewise affected following Jag1 and Rbpj knockdown, we measured actively proliferating cells using a flow cytometric-based EdU incorporation assay. As shown in Fig. 7C and 7D, knockdown of either Jag1 or Rbpj resulted in an increased rate of granulosa cell proliferation compared with controls.

Assessment of intracellular signaling pathways following Jag1 or Rbpj knockdown

To begin uncovering mechanisms mediating the influence of Notch signaling on steroid biosynthesis and proliferation, we initially investigated expression of genes encoding transcription factors including Nr5a1 (Sf1), Nr5a2 (Lrh1), Gata4, and Creb, whose protein products positively regulate expression of Star, Cyp11a1, and Cyp19a1 (35–37). At the transcriptional level, expression of these factors is not changed following Jag1 or Rbpj knockdown (data not shown). The mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase (PI3K)/AKT pathways are understood to regulate differentiated granulosa cell phenotypes in a cyclic adenosine monophosphate/protein kinase A (PKA)–dependent manner, including proliferation (14, 38, 39) and regulation of gene expression (40–43). In the granulosa cell culture system, MAPK/ERK and PI3K/AKT pathway activity decreases as the culture period progresses (Supplemental Fig. 3), correlating with the decreasing proliferation observed in these cells (Fig. 5).

ERK1/2 and AKT phosphorylation levels are increased in Jag1 (Fig. 8A and 8C) or Rbpj (Fig. 8B and 8D) siRNA transfected samples compared with siScramble controls. A closer analysis of the 3-day period of siRNA transfection (siJag1 and siScramble samples; Supplemental Fig. 4) reveals that the observed kinase pathway activity is the result of maintenance of phospho-ERK1/2 at levels comparable to early times of the culture, preventing the loss that occurs with normal differentiation. It has been reported that in granulosa cells, proliferation is achieved in part through transcription of the cell cycle gene Ccnd2 following inactivation of the transcriptional repressor FOXO1, downstream of the AKT pathway (14). We observed enhanced phosphorylation at Ser256 of FOXO1 following Jag1 or Rbpj knockdown, indicating its inactivation (Fig. 8C and 8D). Consistent with this result, Ccnd2 expression was increased more than twofold following Jag1 knockdown (Fig. 9A). Whereas Ccnd2 was not changed following Rbpj knockdown, another cell cycle regulator, cyclin-dependent kinase 1 (Cdk1), was found to be upregulated in these samples (as well as siJag1 samples; Fig. 9A and 9B).

Jag1 or Rbpj knockdown is associated with activation of the MAPK and AKT pathways. To identify activity of the MAPK/ERK and PI3K/AKT pathways following Jag1 and Rbpj knockdown, phosphorylation of ERK1/2 (Thr202/Tyr204) and AKT (Ser473) was analyzed using (A, B) western blots. (C and D) Quantification of the blots is presented. Increased phosphorylation of ERK1/2 (Thr202/Tyr204) and AKT (Ser473) was observed in siJag1 and siRbpj lysates compared with the nontargeting siScramble. The total level of ERK1/2 was also elevated in siJag1 and siRBPJ compared with siScramble. Phosphorylation of the transcriptional repressor FOXO1 (Ser256) is higher in both siJag1 and siRbpj samples compared with siScramble. YB-1 activation (phosphorylation at Ser102) is unchanged following Rbpj knockdown but is downregulated in siJag1 samples compared with control. n = 3; *P < 0.05 compared with siScramble.
Figure 8.

Jag1 or Rbpj knockdown is associated with activation of the MAPK and AKT pathways. To identify activity of the MAPK/ERK and PI3K/AKT pathways following Jag1 and Rbpj knockdown, phosphorylation of ERK1/2 (Thr202/Tyr204) and AKT (Ser473) was analyzed using (A, B) western blots. (C and D) Quantification of the blots is presented. Increased phosphorylation of ERK1/2 (Thr202/Tyr204) and AKT (Ser473) was observed in siJag1 and siRbpj lysates compared with the nontargeting siScramble. The total level of ERK1/2 was also elevated in siJag1 and siRBPJ compared with siScramble. Phosphorylation of the transcriptional repressor FOXO1 (Ser256) is higher in both siJag1 and siRbpj samples compared with siScramble. YB-1 activation (phosphorylation at Ser102) is unchanged following Rbpj knockdown but is downregulated in siJag1 samples compared with control. n = 3; *P < 0.05 compared with siScramble.

(A) Expression of cell cycle regulators is increased following knockdown of Jag1 or Rbpj. siJag1 resulted in upregulation of Cdk1 and Ccnd2 mRNA expression. (B) Cdk1 but not Ccnd2 was upregulated following Rbpj knockdown. n = 3; *P < 0.05 compared with siScramble.
Figure 9.

(A) Expression of cell cycle regulators is increased following knockdown of Jag1 or Rbpj. siJag1 resulted in upregulation of Cdk1 and Ccnd2 mRNA expression. (B) Cdk1 but not Ccnd2 was upregulated following Rbpj knockdown. n = 3; *P < 0.05 compared with siScramble.

We proceeded to test the consequences of altered MAPK/ERK or PI3K/AKT activity following Notch disruption in granulosa cells. As MAPK/ERK pathway activity is more robustly retained following Jag1 knockdown, although the same is true for PI3K/AKT pathway activity following Rbpj knockdown (Fig. 8), we used the MEK inhibitor PD98059 in Jag1 knockdown cells and the AKT inhibitor MK2206 in Rbpj knockdown cells. Inhibitors were used at doses that normalized ERK phosphorylation or AKT phosphorylation to levels comparable to those observed siScramble samples (data not shown). The enhanced observed proliferation following Jag1 knockdown was returned to that of siScramble samples following addition of PD98059 (Fig. 10A). In contrast, AKT inhibition using MK2206 had no effect on siRbpj or siScramble granulosa cells (Fig. 10B). Neither inhibitor affected the reduced expression of steroid biosynthetic genes seen following Jag1 nor Rbpj knockdown.

MAPK/ERK pathway inhibition abrogates enhanced granulosa cell proliferation following Jag1 knockdown. (A) Addition of 4 μM of MEK inhibitor PD98059 reduced the enhanced proliferation observed in siJag1 to that of the siScramble control. The baseline of granulosa cell proliferation in siScramble is unchanged by the addition of PD98059. (B) Inhibition of the AKT pathway using 10 nM of MK2206 did not impact proliferation in siRbpj or siScramble samples. n = 3; means not sharing the same letter are significantly different; P < 0.05.
Figure 10.

MAPK/ERK pathway inhibition abrogates enhanced granulosa cell proliferation following Jag1 knockdown. (A) Addition of 4 μM of MEK inhibitor PD98059 reduced the enhanced proliferation observed in siJag1 to that of the siScramble control. The baseline of granulosa cell proliferation in siScramble is unchanged by the addition of PD98059. (B) Inhibition of the AKT pathway using 10 nM of MK2206 did not impact proliferation in siRbpj or siScramble samples. n = 3; means not sharing the same letter are significantly different; P < 0.05.

We next sought to understand the observed suppression in steroid biosynthetic enzyme gene expression following Jag1 or Rbpj knockdown. Previous studies have shown that the MAPK pathway stimulates expression of granulosa cell genes involved in steroid biosynthesis through activation of the nucleic acid binding protein Y-Box–binding protein-1 (YB-1) (40). Indeed, following Jag1 knockdown, phosphorylation of YB-1 was decreased by 27% despite the observed activation of ERK1/2 (Fig. 8C). Downregulation of YB-1 phosphorylation was not observed following Rbpj knockdown (Fig. 8D), which may contribute to the less robust suppression in gene expression and steroidogenesis observed in the Rbpj-depleted granulosa cells.

Discussion

Progression through ovarian follicular development requires coordinated cell signaling and activation or repression of gene expression in a spatially and temporally restricted fashion. Although FSH and LH are indispensable for follicle growth, maturation, and eventual ovulation, their actions are achieved through interactions with local intraovarian signals. Stimulation of granulosa cell proliferation following FSHR activation requires coactivation by Smad2 and Smad3, which function redundantly in granulosa cells, by activin (14, 44), whereas FSH induction of preovulatory phenotypes in granulosa cells requires several concurrent paracrine cues, including, but not limited to, IGF1R, canonical Wnt, and ERβ signaling (45–47). Later during ovulation, EGF ligands and EGFR signaling are required to transduce LH actions to the oocyte (48). In this study, using the transgenic Notch reporter line, we showed that the Notch signaling pathway in the mouse ovary is active in gonadotropin-responsive follicles of all stages as well as in CL. Our data support previous reports that Notch signaling components are expressed in adult cycling ovaries (24, 25). The current study adds to that knowledge by providing evidence that ovarian Notch signaling is regulated by gonadotropins and is important for granulosa cell differentiation toward a steroidogenic phenotype.

We find the mRNA expression of several Notch receptors and ligands to be upregulated in response to hCG in vivo. Among these is the gene encoding the ligand Jag1, which was previously postulated to be a germ cell–specific Notch ligand (10, 12), with limited expression in the corpus luteum in adult cycling mice (24, 25). Although the periovulatory upregulation of Jag1 expression may signify its potential role during the ovulatory cascade, findings on the localization and identity of JAG1-expressing cells suggest an additional or alternative role. We found that following hormone stimulation, JAG1 becomes localized to both follicular, luteal, and interstitial somatic cells, structures that are identified to be steroidogenic through P450SCC staining. The transient upregulation of Jag1 mRNA likely signifies the initiation of Jag1 expression in somatic cells, as while mRNA levels return to baseline, protein IF indicates a substantial shift away from oocyte-restricted expression toward that in steroidogenic somatic cells.

To further investigate the role of somatic cell–expressed JAG1, we elected to use primary granulosa cells grown under conditions where the cells spontaneously differentiate toward a steroidogenic phenotype (33). We recognize that the cues promoting differentiation in this cell culture model are distinct from those operative in vivo during the periovulatory period. Nonetheless, there are clear phenotypic similarities in granulosa cells from these two models, and cell culture allows direct and transient approaches to manipulating the Notch signaling pathway. One unexpected observation in the cell culture model was the gradual decline in JAG1 levels with time. This may represent transendocytosis of the ligand with active Notch signaling (49, 50), compensation for enhanced Notch2 expression, or an increasing functional role for JAG2, which is reported to be expressed in granulosa cells of growing follicles (25, 32).

A role for Jag1 in promoting granulosa cell differentiation is supported by the observation that following depletion of Jag1, both E2 and P4 production are suppressed through reduced expression of factors and enzymes in the steroid biosynthetic cascade. Concurrent suppression of E2 and P4 following Jag1 or Rbpj knockdown can be explained in part by downregulation of Star, the cofactor responsible for initiating the steroid biosynthetic cascade by transporting cholesterol substrate to the inner mitochondria membrane. This, along with the in vivo findings regarding gonadotropin-regulated Notch activity, suggests that in the cycling ovary, Notch signaling promotes the differentiated granulosa cell phenotype to ensure an optimal response to the ovulatory cue. Additionally, because JAG1 continues to be detected and the Notch reporter is active in the CL, it is likely that Notch signaling also functions to promote and maintain the terminally differentiated luteal phenotype.

JAG1 localizes to somatic cells that are Notch active based on observations made in the transgenic Notch reporter mouse, which suggests that the action of JAG1 in these cells is achieved through canonical Notch signaling. Knockdown of the Notch obligate cofactor Rbpj in cultured granulosa cells results in similar steroidogenic suppression, albeit slightly less robust compared with that observed in the Jag1 knockdown. Although differences in the efficiency of Jag1 and Rbpj knockdown most likely explain the variance in the degree of suppression of steroid biosynthesis, it is important to note the role of Rbpj in transcriptional repression of Notch target genes. Prior to Notch activation and subsequent NICD binding to promoters and recruitment of transcriptional coactivators such as Maml, Rbpj suppresses gene expression through interactions with transcriptional corepressors and/or histone deacetylases (15, 17, 51). The compensatory effects due to the loss of target gene repression by Rbpj in the basal state has been demonstrated in Drosophila melanogaster in which the loss of Su(H), the homolog to mammalian Rbpj, leads to weaker phenotypes than the loss of Notch in several developmental processes, including bristle formation, wing development, and dorsal-ventral boundary formation (52–54). In murine fibroblast cells, p53 expression was found to be suppressed by the binding of Rbpj to its promoter in a cell cycle–dependent manner (51). Thus, depletion of Rbpj may lead to broader changes that result in a blunted phenotype compared with the depletion of Jag1, the specific ligand that appears to initiate the Notch signal in these differentiating granulosa cells.

The in vivo findings of robust Notch activity in growing follicles and CL, as well as results from the in vitro functional studies, raise questions regarding the identities of the sending and receiving cells engaged in this contact-dependent signaling. Our previous work (12) concerning the role of Notch signaling during germ cell nest breakdown posits a model in which the ligand JAG1 from the oocytes interacts with the NOTCH2 receptor on intimately associated granulosa cells. Once follicles are recruited to the growing pool, however, deposition of the zona pellucida matrix is likely to create a partial physical barrier to contact-dependent signaling. Also, as the follicle expands, the most distal mural granulosa cells are far removed from contact with the oocyte. Thus, the most parsimonious explanation for the observation of continued Notch activity in growing follicles, CL, and cultured granulosa cells is the expression of both Notch ligand(s) and receptor(s) by granulosa cells (and later luteal cells), allowing for ligand-receptor interaction in a trans-manner between neighboring cells. This is consistent with the somatic cell localization of JAG1 following hormone stimulation, additional reports of ligand and receptor expression in granulosa cells throughout the entirety of follicular development (32), and the observation that the Notch reporter remains active in granulosa cells cultured from TNR ovaries (our unpublished observations).

Notch activity in multilayer follicles (and later CL) likely is maintained through lateral induction, where the Notch signal is propagated among adjacent cells through positive feedback regulation of Notch ligand expression following Notch receptor transactivation (55). It is reasonable to speculate that Notch ligands in the oocyte act to initiate signaling within the first layers of granulosa cells, which in turn relay Notch signals to more distal granulosa cells by way of lateral induction. Physiologically, the importance of such lateral induction mechanisms in Notch signaling can be seen in the developing inner ear where Jag1 maintains a patch of sensory progenitor cells (56). Ectopic expression of NICD in the nonsensory epithelium was shown to cause increased Jag1 expression, which was in turn sufficient to induce expression of sensory progenitor markers (57). Jag1 and Notch2 are also coexpressed in cells of the peripheral lens epithelium where they function to promote fibroblast growth factor–dependent lens fiber differentiation (58). Finally, Jag1 has been identified as a direct canonical Notch target gene in cardiac neural crest, where Notch signaling is responsible for the differentiation of smooth muscle cells required for the assembly of the multilayered arterial wall (59). These examples demonstrate the importance of lateral induction of Notch signaling in regulating differentiation events in diverse systems.

The suppressed steroid biosynthesis observed following Jag1 or Rbpj knockdown is similar to that reported in DAPT-treated luteal cells (60–62) and in response to Mamld1 knockdown in mouse Leydig tumor cells (63). In terminally differentiated luteal cells, reduced P4 secretion due to Notch inhibition resulted in cellular apoptosis (60, 61). In contrast to these studies, Jag1 or Rbpj knockdown in differentiating granulosa cells not only caused a reduction in the fraction of apoptosing cells, but also led to an increase in the percentage of cells in the S-phase of the cell cycle, indicating a retention of proliferative potential. These differences are not entirely surprising because, in contrast to differentiating granulosa cells, luteal cells lack the capacity to proliferate and require P4 for survival (64). Although proliferation and differentiation can happen concurrently, and both are hormonally driven by FSH in granulosa cells, these events are also well known to occur in an autonomous manner. An example is the Cyclind2 null mouse, in which follicles with severely impaired granulosa cell proliferation remain steroidogenically active and are able to mature and eventually terminally differentiate into a luteal state (although they lack the ability to be ovulated) (31).

It is likely that the diverse functions of Notch within the follicle are achieved through interactions with underlying intracellular signaling landscapes that are distinct at different developmental stages. Numerous studies have shown the importance of PI3K/AKT and MAPK/ERK signaling in promoting proliferation and gene expression in granulosa cells (14, 38–43). Activation of the PI3K/AKT and MAPK/ERK pathways resulting in increased expression of the cell cycle genes Ccnd2 and Cdk1 provides a molecular mechanism for the observed retention of proliferative potential in cultured granulosa cells following Jag1 or Rbpj knockdown. The MAPK/ERK pathway, however, can also promote expression of differentiation-associated genes, including Cyp19a1 and Cyp11a1 (40, 41, 43). Our results reveal that the enhanced activation of the MAPK/ERK pathway that is observed following Jag1 or Rbpj knockdown represents retention of a less differentiated phenotype, consistent with the cells being less steroidogenic and more proliferative. Indeed, inhibition of the MAPK/ERK pathway using the MEK inhibitor PD98059 following Jag1 knockdown normalized the proliferation rate to that observed in the siScramble control, which suggests that in cultured primary granulosa cells, the MAPK/ERK pathway is strongly associated with proliferation. More recently, it has been shown that expression of granulosa cell differentiation-associated genes through the MAPK/ERK pathway requires activation of the DNA- and RNA-binding protein YB-1 (40). We found that despite enhanced MAPK/ERK pathway activity, YB-1 phosphorylation is downregulated following Jag1 knockdown, which may begin to explain the observed suppression of steroidogenic gene expression, despite the increased activation of prodifferentiation intercellular signals.

It remains to be explored how disruption of canonical Notch signaling leads to alterations in signal transducers such as PI3K/AKT, MAPK/ERK, and YB-1 in granulosa cells. In this regard, there are examples of Notch signaling modulating differentiation and proliferation through interactions with intracellular kinase cascades. Interplay between Notch and receptor tyrosine kinase signaling has been found to be important in the decision-making process between self-renewal and differentiation in the various follicle somatic cell types of the Drosophila ovariole (65). A balance between Notch signaling and the MAPK/ERK pathway, downstream of the fibroblast growth factor receptor, in Sertoli cells is thought to be important in maintaining cyclical recruitment of quiescent prospermatogonia into spermatogenesis (66). Another example of cross-talk between Notch signaling and the MAPK pathway was observed in myotube differentiation from muscle precursors, where MKP-1, a MAPK phosphatase, is regulated in an Rbpj-dependent manner (67). Together, these examples and our data demonstrate that the Notch pathway has the potential to interact with diverse types of intracellular signals to regulate cellular activity.

In summary, we have described a key role for Notch signaling in promoting differentiation and in negatively regulating proliferation in mouse granulosa cells. Our findings suggest that activation of Notch signaling by the ligand Jag1 impacts multiple kinase cascades that are important in control of proliferation and promotion of gene expression leading to granulosa cell differentiation. Considering both our in vivo and in vitro data, we demonstrate that, like many other local factors important during the periovulatory period (45–47), Notch signaling promotes a differentiated phenotype that is initiated by gonadotropin signaling. Understanding how Notch signaling regulates the balance between differentiation and proliferation in granulosa cells promises further insights into the periovulatory period, where the maturing follicle needs to sustain an FSH-dependent differentiated state so as to optimally respond to LH and successfully ovulate a healthy fertilizable egg. Our finding that Notch signaling has a role in promoting the differentiation of granulosa cells adds to the growing and diverse functions for Notch in the mammalian ovary and in reproduction.

Appendix.

Antibody Table

Peptide/Protein TargetName of AntibodyManufacturer; Catalog No.Species Raised In; Monoclonal or PolyclonalDilution UsedRRID
JAG1Goat anti-JAG1Santa Cruz Biotechnology; SC-6011Goat; polyclonal1:200 for western blot; 1:50 for IFAB_649689
P450SCCRabbit anti-P450SCCCell Signaling Technology; 14217Rabbit; monoclonal1:800 for IFAB_2631970
GFPRabbit anti-GFPLife Technology; A11122Rabbit; polyclonal1:200 for IHCAB_221569
NOTCH2Rat anti-Notch2Developmental Studies Hybridoma Bank; C651.6DbHNRat; monoclonal1.8 μg/mL for western blotAB_528412
RBPJRabbit anti-RBPJAbcam 25949Rabbit; polyclonal1:1000 for western blotAB_778155
GAPDHRabbit anti-GAPDHCell Signaling Technology; 2118Rabbit; monoclonal1:10,000 for western blotAB_561053
panAKTRabbit anti-panAKTCell Signaling Technology; 4691Rabbit; monoclonal1:1000 for western blotAB_915783
ERK1/2Rabbit anti-ERK1/2Cell Signaling Technology; 4695Rabbit; monoclonal1:1000 for western blotAB_390779
phosphoAKT (Ser473)Rabbit anti-pAKTCell Signaling Technology; 4060Rabbit; monoclonal1:2000 for western blotAB_2315049
phosphoERK1/2 (Thr202; Tyr204)Rabbit anti-pERK1/2Cell Signaling Technology; 9101Rabbit; polyclonal1:1000 for western blotAB_331646
FOXO1Rabbit anti-FOXO1Cell Signaling Technology; 2880Rabbit; monoclonal1:1000 for western blotAB_2106495
phosphoFOXO1 (Ser256)Rabbit anti-pFOXO1Cell Signaling Technology; 9461Rabbit; polyclonal1:1000 for western blotAB_329831
YB-1Rabbit anti-YB1Cell Signaling Technology; 8475Rabbit; monoclonal1:1000 for western blotAB_11179070
phosphoYB-1 (Ser102)Rabbit anti-pYB1Cell Signaling Technology; 2900Rabbit; monoclonal1:1000 for western blotAB_2219273
IgG rabbitIRDye 800CW Goat anti-Rabbit IgGLI-COR; 925-32211Goat; polyclonal1:5000 for western blotAB_2651127
IgG rabbitIRDye 680RD Donkey anti-Rabbit IgGLI-COR; 926-68073Donkey; polyclonal1:5000 for western blotAB_10954442
IgG goatIRDye 800CW Donkey anti-Goat IgGLI-COR; 925-32214Donkey; polyclonal1:5000 for western blotAB_2687553
IgG ratIRDye 800CW Goat anti-Rat IgGLI-COR; 926-32219Goat; polyclonal1:5000 for western blotAB_1850025
IgG ratIRDye 680RD Goat anti-Rat IgGLI-COR; 926-68076Goat; polyclonal1:5000 for western blotAB_10956590
Peptide/Protein TargetName of AntibodyManufacturer; Catalog No.Species Raised In; Monoclonal or PolyclonalDilution UsedRRID
JAG1Goat anti-JAG1Santa Cruz Biotechnology; SC-6011Goat; polyclonal1:200 for western blot; 1:50 for IFAB_649689
P450SCCRabbit anti-P450SCCCell Signaling Technology; 14217Rabbit; monoclonal1:800 for IFAB_2631970
GFPRabbit anti-GFPLife Technology; A11122Rabbit; polyclonal1:200 for IHCAB_221569
NOTCH2Rat anti-Notch2Developmental Studies Hybridoma Bank; C651.6DbHNRat; monoclonal1.8 μg/mL for western blotAB_528412
RBPJRabbit anti-RBPJAbcam 25949Rabbit; polyclonal1:1000 for western blotAB_778155
GAPDHRabbit anti-GAPDHCell Signaling Technology; 2118Rabbit; monoclonal1:10,000 for western blotAB_561053
panAKTRabbit anti-panAKTCell Signaling Technology; 4691Rabbit; monoclonal1:1000 for western blotAB_915783
ERK1/2Rabbit anti-ERK1/2Cell Signaling Technology; 4695Rabbit; monoclonal1:1000 for western blotAB_390779
phosphoAKT (Ser473)Rabbit anti-pAKTCell Signaling Technology; 4060Rabbit; monoclonal1:2000 for western blotAB_2315049
phosphoERK1/2 (Thr202; Tyr204)Rabbit anti-pERK1/2Cell Signaling Technology; 9101Rabbit; polyclonal1:1000 for western blotAB_331646
FOXO1Rabbit anti-FOXO1Cell Signaling Technology; 2880Rabbit; monoclonal1:1000 for western blotAB_2106495
phosphoFOXO1 (Ser256)Rabbit anti-pFOXO1Cell Signaling Technology; 9461Rabbit; polyclonal1:1000 for western blotAB_329831
YB-1Rabbit anti-YB1Cell Signaling Technology; 8475Rabbit; monoclonal1:1000 for western blotAB_11179070
phosphoYB-1 (Ser102)Rabbit anti-pYB1Cell Signaling Technology; 2900Rabbit; monoclonal1:1000 for western blotAB_2219273
IgG rabbitIRDye 800CW Goat anti-Rabbit IgGLI-COR; 925-32211Goat; polyclonal1:5000 for western blotAB_2651127
IgG rabbitIRDye 680RD Donkey anti-Rabbit IgGLI-COR; 926-68073Donkey; polyclonal1:5000 for western blotAB_10954442
IgG goatIRDye 800CW Donkey anti-Goat IgGLI-COR; 925-32214Donkey; polyclonal1:5000 for western blotAB_2687553
IgG ratIRDye 800CW Goat anti-Rat IgGLI-COR; 926-32219Goat; polyclonal1:5000 for western blotAB_1850025
IgG ratIRDye 680RD Goat anti-Rat IgGLI-COR; 926-68076Goat; polyclonal1:5000 for western blotAB_10956590

Abbreviation: IgG, immunoglobulin G; RRID, Research Resource Identifier.

Appendix.

Antibody Table

Peptide/Protein TargetName of AntibodyManufacturer; Catalog No.Species Raised In; Monoclonal or PolyclonalDilution UsedRRID
JAG1Goat anti-JAG1Santa Cruz Biotechnology; SC-6011Goat; polyclonal1:200 for western blot; 1:50 for IFAB_649689
P450SCCRabbit anti-P450SCCCell Signaling Technology; 14217Rabbit; monoclonal1:800 for IFAB_2631970
GFPRabbit anti-GFPLife Technology; A11122Rabbit; polyclonal1:200 for IHCAB_221569
NOTCH2Rat anti-Notch2Developmental Studies Hybridoma Bank; C651.6DbHNRat; monoclonal1.8 μg/mL for western blotAB_528412
RBPJRabbit anti-RBPJAbcam 25949Rabbit; polyclonal1:1000 for western blotAB_778155
GAPDHRabbit anti-GAPDHCell Signaling Technology; 2118Rabbit; monoclonal1:10,000 for western blotAB_561053
panAKTRabbit anti-panAKTCell Signaling Technology; 4691Rabbit; monoclonal1:1000 for western blotAB_915783
ERK1/2Rabbit anti-ERK1/2Cell Signaling Technology; 4695Rabbit; monoclonal1:1000 for western blotAB_390779
phosphoAKT (Ser473)Rabbit anti-pAKTCell Signaling Technology; 4060Rabbit; monoclonal1:2000 for western blotAB_2315049
phosphoERK1/2 (Thr202; Tyr204)Rabbit anti-pERK1/2Cell Signaling Technology; 9101Rabbit; polyclonal1:1000 for western blotAB_331646
FOXO1Rabbit anti-FOXO1Cell Signaling Technology; 2880Rabbit; monoclonal1:1000 for western blotAB_2106495
phosphoFOXO1 (Ser256)Rabbit anti-pFOXO1Cell Signaling Technology; 9461Rabbit; polyclonal1:1000 for western blotAB_329831
YB-1Rabbit anti-YB1Cell Signaling Technology; 8475Rabbit; monoclonal1:1000 for western blotAB_11179070
phosphoYB-1 (Ser102)Rabbit anti-pYB1Cell Signaling Technology; 2900Rabbit; monoclonal1:1000 for western blotAB_2219273
IgG rabbitIRDye 800CW Goat anti-Rabbit IgGLI-COR; 925-32211Goat; polyclonal1:5000 for western blotAB_2651127
IgG rabbitIRDye 680RD Donkey anti-Rabbit IgGLI-COR; 926-68073Donkey; polyclonal1:5000 for western blotAB_10954442
IgG goatIRDye 800CW Donkey anti-Goat IgGLI-COR; 925-32214Donkey; polyclonal1:5000 for western blotAB_2687553
IgG ratIRDye 800CW Goat anti-Rat IgGLI-COR; 926-32219Goat; polyclonal1:5000 for western blotAB_1850025
IgG ratIRDye 680RD Goat anti-Rat IgGLI-COR; 926-68076Goat; polyclonal1:5000 for western blotAB_10956590
Peptide/Protein TargetName of AntibodyManufacturer; Catalog No.Species Raised In; Monoclonal or PolyclonalDilution UsedRRID
JAG1Goat anti-JAG1Santa Cruz Biotechnology; SC-6011Goat; polyclonal1:200 for western blot; 1:50 for IFAB_649689
P450SCCRabbit anti-P450SCCCell Signaling Technology; 14217Rabbit; monoclonal1:800 for IFAB_2631970
GFPRabbit anti-GFPLife Technology; A11122Rabbit; polyclonal1:200 for IHCAB_221569
NOTCH2Rat anti-Notch2Developmental Studies Hybridoma Bank; C651.6DbHNRat; monoclonal1.8 μg/mL for western blotAB_528412
RBPJRabbit anti-RBPJAbcam 25949Rabbit; polyclonal1:1000 for western blotAB_778155
GAPDHRabbit anti-GAPDHCell Signaling Technology; 2118Rabbit; monoclonal1:10,000 for western blotAB_561053
panAKTRabbit anti-panAKTCell Signaling Technology; 4691Rabbit; monoclonal1:1000 for western blotAB_915783
ERK1/2Rabbit anti-ERK1/2Cell Signaling Technology; 4695Rabbit; monoclonal1:1000 for western blotAB_390779
phosphoAKT (Ser473)Rabbit anti-pAKTCell Signaling Technology; 4060Rabbit; monoclonal1:2000 for western blotAB_2315049
phosphoERK1/2 (Thr202; Tyr204)Rabbit anti-pERK1/2Cell Signaling Technology; 9101Rabbit; polyclonal1:1000 for western blotAB_331646
FOXO1Rabbit anti-FOXO1Cell Signaling Technology; 2880Rabbit; monoclonal1:1000 for western blotAB_2106495
phosphoFOXO1 (Ser256)Rabbit anti-pFOXO1Cell Signaling Technology; 9461Rabbit; polyclonal1:1000 for western blotAB_329831
YB-1Rabbit anti-YB1Cell Signaling Technology; 8475Rabbit; monoclonal1:1000 for western blotAB_11179070
phosphoYB-1 (Ser102)Rabbit anti-pYB1Cell Signaling Technology; 2900Rabbit; monoclonal1:1000 for western blotAB_2219273
IgG rabbitIRDye 800CW Goat anti-Rabbit IgGLI-COR; 925-32211Goat; polyclonal1:5000 for western blotAB_2651127
IgG rabbitIRDye 680RD Donkey anti-Rabbit IgGLI-COR; 926-68073Donkey; polyclonal1:5000 for western blotAB_10954442
IgG goatIRDye 800CW Donkey anti-Goat IgGLI-COR; 925-32214Donkey; polyclonal1:5000 for western blotAB_2687553
IgG ratIRDye 800CW Goat anti-Rat IgGLI-COR; 926-32219Goat; polyclonal1:5000 for western blotAB_1850025
IgG ratIRDye 680RD Goat anti-Rat IgGLI-COR; 926-68076Goat; polyclonal1:5000 for western blotAB_10956590

Abbreviation: IgG, immunoglobulin G; RRID, Research Resource Identifier.

Abbreviations:

     
  • AKT

    protein kinase B

  •  
  • Ccnd2

    cyclin D2

  •  
  • Cdk1

    cyclin-dependent kinase 1

  •  
  • CL

    corpora lutea

  •  
  • CV%

    coefficient of variation

  •  
  • DAPT

    N-(N-(3,5-difluorophenacetyl)-l-alanyl)-S-phenylglycine t-butyl ester

  •  
  • E2

    estradiol-17β

  •  
  • EdU

    5-ethynyl-2′-deoxyuridine

  •  
  • ELISA

    enzyme-linked immunosorbent assay

  •  
  • ERK

    extracellular signal-regulated kinase

  •  
  • FSH

    follicle-stimulating hormone

  •  
  • FSHR

    follicle-stimulating hormone receptor

  •  
  • hCG

    human chorionic gonadotropin

  •  
  • IF

    immunofluorescence

  •  
  • IHC

    immunohistochemistry

  •  
  • IP

    intraperitoneal

  •  
  • LH

    luteinizing hormone

  •  
  • MAPK

    mitogen-activated protein kinase

  •  
  • MEK

    mitogen-activated protein kinase kinase

  •  
  • mRNA

    messenger RNA

  •  
  • NICD

    Notch intercellular domain

  •  
  • P4

    progesterone

  •  
  • P450SCC

    P450 side-chain cleavage

  •  
  • PI

    propidium iodide

  •  
  • PI3K

    phosphatidylinositol 3-kinase

  •  
  • PMSG

    pregnant mare’s serum gonadotropin

  •  
  • PND

    postnatal day

  •  
  • qRT-PCR

    quantitative real-time polymerase chain reaction

  •  
  • siRNA

    small interfering RNA

  •  
  • TNR

    transgenic Notch responsive

  •  
  • YB-1

    Y-Box–binding protein-1.

Acknowledgments

Financial Support: This work was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant P01 HD021921 (to K.E.M.), the Cellular and Molecular Basis of Disease Training Program through National Institutes of Health/Institute of General Medical Sciences Grant T32 GM008061 (to R.D.P.), and the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core through Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health Grant P50-HD28934.

Disclosure Summary: The authors have nothing to disclose.

References

1.

Chen
Y
,
Jefferson
WN
,
Newbold
RR
,
Padilla-Banks
E
,
Pepling
ME
.
Estradiol, progesterone, and genistein inhibit oocyte nest breakdown and primordial follicle assembly in the neonatal mouse ovary in vitro and in vivo
.
Endocrinology
.
2007
;
148
(
8
):
3580
3590
.

2.

Chen
Y
,
Breen
K
,
Pepling
ME
.
Estrogen can signal through multiple pathways to regulate oocyte cyst breakdown and primordial follicle assembly in the neonatal mouse ovary
.
J Endocrinol
.
2009
;
202
(
3
):
407
417
.

3.

Mu
X
,
Liao
X
,
Chen
X
,
Li
Y
,
Wang
M
,
Shen
C
,
Zhang
X
,
Wang
Y
,
Liu
X
,
He
J
.
DEHP exposure impairs mouse oocyte cyst breakdown and primordial follicle assembly through estrogen receptor-dependent and independent mechanisms
.
J Hazard Mater
.
2015
;
298
:
232
240
.

4.

Kezele
P
,
Skinner
MK
.
Regulation of ovarian primordial follicle assembly and development by estrogen and progesterone: endocrine model of follicle assembly
.
Endocrinology
.
2003
;
144
(
8
):
3329
3337
.

5.

Hutt
KJ
,
McLaughlin
EA
,
Holland
MK
.
Kit ligand and c-Kit have diverse roles during mammalian oogenesis and folliculogenesis
.
Mol Hum Reprod
.
2006
;
12
(
2
):
61
69
.

6.

Jones
RL
,
Pepling
ME
.
KIT signaling regulates primordial follicle formation in the neonatal mouse ovary
.
Dev Biol
.
2013
;
382
(
1
):
186
197
.

7.

Kimura
F
,
Bonomi
LM
,
Schneyer
AL
.
Follistatin regulates germ cell nest breakdown and primordial follicle formation
.
Endocrinology
.
2011
;
152
(
2
):
697
706
.

8.

Bristol-Gould
SK
,
Kreeger
PK
,
Selkirk
CG
,
Kilen
SM
,
Cook
RW
,
Kipp
JL
,
Shea
LD
,
Mayo
KE
,
Woodruff
TK
.
Postnatal regulation of germ cells by activin: the establishment of the initial follicle pool
.
Dev Biol
.
2006
;
298
(
1
):
132
148
.

9.

Kipp
JL
,
Kilen
SM
,
Bristol-Gould
S
,
Woodruff
TK
,
Mayo
KE
.
Neonatal exposure to estrogens suppresses activin expression and signaling in the mouse ovary
.
Endocrinology
.
2007
;
148
(
5
):
1968
1976
.

10.

Trombly
DJ
,
Woodruff
TK
,
Mayo
KE
.
Suppression of Notch signaling in the neonatal mouse ovary decreases primordial follicle formation
.
Endocrinology
.
2009
;
150
(
2
):
1014
1024
.

11.

Xu
J
,
Gridley
T
.
Notch2 is required in somatic cells for breakdown of ovarian germ-cell nests and formation of primordial follicles
.
BMC Biol
.
2013
;
11
(
1
):
13
.

12.

Vanorny
DA
,
Prasasya
RD
,
Chalpe
AJ
,
Kilen
SM
,
Mayo
KE
.
Notch signaling regulates ovarian follicle formation and coordinates follicular growth
.
Mol Endocrinol
.
2014
;
28
(
4
):
499
511
.

13.

Richards
JS
.
Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation
.
Physiol Rev
.
1980
;
60
(
1
):
51
89
.

14.

Park
Y
,
Maizels
ET
,
Feiger
ZJ
,
Alam
H
,
Peters
CA
,
Woodruff
TK
,
Unterman
TG
,
Lee
EJ
,
Jameson
JL
,
Hunzicker-Dunn
M
.
Induction of cyclin D2 in rat granulosa cells requires FSH-dependent relief from FOXO1 repression coupled with positive signals from Smad
.
J Biol Chem
.
2005
;
280
(
10
):
9135
9148
.

15.

Kopan
R
,
Ilagan
MXG
.
The canonical Notch signaling pathway: unfolding the activation mechanism
.
Cell
.
2009
;
137
(
2
):
216
233
.

16.

Mumm
JS
,
Schroeter
EH
,
Saxena
MT
,
Griesemer
A
,
Tian
X
,
Pan
DJ
,
Ray
WJ
,
Kopan
R
.
A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1
.
Mol Cell
.
2000
;
5
(
2
):
197
206
.

17.

Kovall
RA
.
More complicated than it looks: assembly of Notch pathway transcription complexes
.
Oncogene
.
2008
;
27
(
38
):
5099
5109
.

18.

Andersson
ER
,
Sandberg
R
,
Lendahl
U
.
Notch signaling: simplicity in design, versatility in function
.
Development
.
2011
;
138
(
17
):
3593
3612
.

19.

Pepling
ME
,
Spradling
AC
.
Mouse ovarian germ cell cysts undergo programmed breakdown to form primordial follicles
.
Dev Biol
.
2001
;
234
(
2
):
339
351
.

20.

Hahn
KL
,
Johnson
J
,
Beres
BJ
,
Howard
S
,
Wilson-Rawls
J
.
Lunatic fringe null female mice are infertile due to defects in meiotic maturation
.
Development
.
2005
;
132
(
4
):
817
828
.

21.

Xu
J
,
Norton
CR
,
Gridley
T
.
Not all lunatic fringe null female mice are infertile
.
Development
.
2006
;
133
(
4
):
579
.

22.

Kageyama
R
,
Ohtsuka
T
,
Kobayashi
T
.
The Hes gene family: repressors and oscillators that orchestrate embryogenesis
.
Development
.
2007
;
134
(
7
):
1243
1251
.

23.

Manosalva
I
,
González
A
,
Kageyama
R
.
Hes1 in the somatic cells of the murine ovary is necessary for oocyte survival and maturation
.
Dev Biol
.
2013
;
375
(
2
):
140
151
.

24.

Johnson
J
,
Espinoza
T
,
McGaughey
RW
,
Rawls
A
,
Wilson-Rawls
J
.
Notch pathway genes are expressed in mammalian ovarian follicles
.
Mech Dev
.
2001
;
109
(
2
):
355
361
.

25.

Murta
D
,
Batista
M
,
Silva
E
,
Trindade
A
,
Mateus
L
,
Duarte
A
,
Lopes-da-Costa
L
.
Differential expression of Notch component and effector genes during ovarian follicle and corpus luteum development during the oestrous cycle
.
Reprod Fertil Dev
.
2015
;
27
(
7
):
1038
1048
.

26.

Richards
JS
,
Russell
DL
,
Ochsner
S
,
Hsieh
M
,
Doyle
KH
,
Falender
AE
,
Lo
YK
,
Sharma
SC
.
Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization
.
Recent Prog Horm Res
.
2002
;
57
(
1
):
195
220
.

27.

Duncan
AW
,
Rattis
FM
,
DiMascio
LN
,
Congdon
KL
,
Pazianos
G
,
Zhao
C
,
Yoon
K
,
Cook
JM
,
Willert
K
,
Gaiano
N
,
Reya
T
.
Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance
.
Nat Immunol
.
2005
;
6
(
3
):
314
322
.

28.

Livak
KJ
,
Schmittgen
TD
.
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
.
Methods
.
2001
;
25
(
4
):
402
408
.

29.

Camp
TA
,
Rahal
JO
,
Mayo
KE
.
Cellular localization and hormonal regulation of follicle-stimulating hormone and luteinizing hormone receptor messenger RNAs in the rat ovary
.
Mol Endocrinol
.
1991
;
5
(
10
):
1405
1417
.

30.

Kipp
JL
,
Kilen
SM
,
Woodruff
TK
,
Mayo
KE
.
Activin regulates estrogen receptor gene expression in the mouse ovary
.
J Biol Chem
.
2007
;
282
(
50
):
36755
36765
.

31.

Sicinski
P
,
Donaher
JL
,
Geng
Y
,
Parker
SB
,
Gardner
H
,
Park
MY
,
Robker
RL
,
Richards
JS
,
McGinnis
LK
,
Biggers
JD
,
Eppig
JJ
,
Bronson
RT
,
Elledge
SJ
,
Weinberg
RA
.
Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis
.
Nature
.
1996
;
384
(
6608
):
470
474
.

32.

Vanorny
DA
,
Mayo
KE
.
The role of Notch signaling in the mammalian ovary
.
Reproduction
.
2017
;
153
(
6
):
R187
R204
.

33.

Channing
CP
.
Influences of the in vivo and in vitro hormonal environment upon luteinization of granulosa cells in tissue culture
.
Recent Prog Horm Res
.
1970
;
26
:
589
622
.

34.

Hsueh
AJ
,
Adashi
EY
,
Jones
PB
,
Welsh
TH
, Jr
.
Hormonal regulation of the differentiation of cultured ovarian granulosa cells
.
Endocr Rev
.
1984
;
5
(
1
):
76
127
.

35.

Lavoie
HA
,
King
SR
.
Transcriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3B
.
Exp Biol Med (Maywood)
.
2009
;
234
(
8
):
880
907
.

36.

Shih
M-CM
,
Chiu
Y-N
,
Hu
M-C
,
Guo
I-C
,
Chung
B-C
.
Regulation of steroid production: analysis of Cyp11a1 promoter
.
Mol Cell Endocrinol
.
2011
;
336
(
1-2
):
80
84
.

37.

Tremblay
JJ
,
Viger
RS
.
GATA factors differentially activate multiple gonadal promoters through conserved GATA regulatory elements
.
Endocrinology
.
2001
;
142
(
3
):
977
986
.

38.

Kayampilly
PP
,
Menon
KMJ
.
Follicle-stimulating hormone inhibits adenosine 5′-monophosphate-activated protein kinase activation and promotes cell proliferation of primary granulosa cells in culture through an Akt-dependent pathway
.
Endocrinology
.
2009
;
150
(
2
):
929
935
.

39.

Kayampilly
PP
,
Menon
KMJ
.
Inhibition of extracellular signal-regulated protein kinase-2 phosphorylation by dihydrotestosterone reduces follicle-stimulating hormone-mediated cyclin D2 messenger ribonucleic acid expression in rat granulosa cells
.
Endocrinology
.
2004
;
145
(
4
):
1786
1793
.

40.

Donaubauer
EM
,
Hunzicker-Dunn
ME
.
Extracellular signal-regulated kinase (ERK)-dependent phosphorylation of Y-box-binding protein 1 (YB-1) enhances gene expression in granulosa cells in response to follicle-stimulating hormone (FSH)
.
J Biol Chem
.
2016
;
291
(
23
):
12145
12160
.

41.

Donaubauer
EM
,
Law
NC
,
Hunzicker-Dunn
ME
.
Follicle-stimulating hormone (FSH)-dependent regulation of extracellular regulated kinase (ERK) phosphorylation by the mitogen-activated protein (MAP) kinase phosphatase MKP3
.
J Biol Chem
.
2016
;
291
(
37
):
19701
19712
.

42.

Herndon
MK
,
Law
NC
,
Donaubauer
EM
,
Kyriss
B
,
Hunzicker-Dunn
M
.
Forkhead box O member FOXO1 regulates the majority of follicle-stimulating hormone responsive genes in ovarian granulosa cells
.
Mol Cell Endocrinol
.
2016
;
434
:
116
126
.

43.

Fan
H-Y
,
Liu
Z
,
Shimada
M
,
Sterneck
E
,
Johnson
PF
,
Hedrick
SM
,
Richards
JS
.
MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility
.
Science
.
2009
;
324
(
5929
):
938
941
.

44.

Li
Q
,
Pangas
SA
,
Jorgez
CJ
,
Graff
JM
,
Weinstein
M
,
Matzuk
MM
.
Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo
.
Mol Cell Biol
.
2008
;
28
(
23
):
7001
7011
.

45.

Zhou
P
,
Baumgarten
SC
,
Wu
Y
,
Bennett
J
,
Winston
N
,
Hirshfeld-Cytron
J
,
Stocco
C
.
IGF-I signaling is essential for FSH stimulation of AKT and steroidogenic genes in granulosa cells
.
Mol Endocrinol
.
2013
;
27
(
3
):
511
523
.

46.

Boyer
A
,
Lapointe
E
,
Zheng
X
,
Cowan
RG
,
Li
H
,
Quirk
SM
,
DeMayo
FJ
,
Richards
JS
,
Boerboom
D
.
WNT4 is required for normal ovarian follicle development and female fertility
.
FASEB J
.
2010
;
24
(
8
):
3010
3025
.

47.

Deroo
BJ
,
Rodriguez
KF
,
Couse
JF
,
Hamilton
KJ
,
Collins
JB
,
Grissom
SF
,
Korach
KS
.
Estrogen receptor beta is required for optimal cAMP production in mouse granulosa cells
.
Mol Endocrinol
.
2009
;
23
(
7
):
955
965
.

48.

Park
J-Y
,
Su
Y-Q
,
Ariga
M
,
Law
E
,
Jin
S-LC
,
Conti
M
.
EGF-like growth factors as mediators of LH action in the ovulatory follicle
.
Science
.
2004
;
303
(
5658
):
682
684
.

49.

Musse
AA
,
Meloty-Kapella
L
,
Weinmaster
G
.
Notch ligand endocytosis: mechanistic basis of signaling activity
.
Semin Cell Dev Biol
.
2012
;
23
(
4
):
429
436
.

50.

Hansson
EM
,
Lanner
F
,
Das
D
,
Mutvei
A
,
Marklund
U
,
Ericson
J
,
Farnebo
F
,
Stumm
G
,
Stenmark
H
,
Andersson
ER
,
Lendahl
U
.
Control of Notch-ligand endocytosis by ligand-receptor interaction
.
J Cell Sci
.
2010
;
123
(
Pt 17
):
2931
2942
.

51.

Boggs
K
,
Henderson
B
,
Reisman
D
.
RBP-Jkappa binds to and represses transcription of the p53 tumor suppressor gene
.
Cell Biol Int
.
2009
;
33
(
3
):
318
324
.

52.

Koelzer
S
,
Klein
T
.
A Notch-independent function of Suppressor of Hairless during the development of the bristle sensory organ precursor cell of Drosophila
.
Development
.
2003
;
130
(
9
):
1973
1988
.

53.

Morel
V
,
Schweisguth
F
.
Repression by suppressor of hairless and activation by Notch are required to define a single row of single-minded expressing cells in the Drosophila embryo
.
Genes Dev
.
2000
;
14
(
3
):
377
388
.

54.

Koelzer
S
,
Klein
T
.
Regulation of expression of Vg and establishment of the dorsoventral compartment boundary in the wing imaginal disc by Suppressor of Hairless
.
Dev Biol
.
2006
;
289
(
1
):
77
90
.

55.

Ross
DA
,
Kadesch
T
.
Consequences of Notch-mediated induction of Jagged1
.
Exp Cell Res
.
2004
;
296
(
2
):
173
182
.

56.

Daudet
N
,
Ariza-McNaughton
L
,
Lewis
J
.
Notch signalling is needed to maintain, but not to initiate, the formation of prosensory patches in the chick inner ear
.
Development
.
2007
;
134
(
12
):
2369
2378
.

57.

Hartman
BH
,
Reh
TA
,
Bermingham-McDonogh
O
.
Notch signaling specifies prosensory domains via lateral induction in the developing mammalian inner ear
.
Proc Natl Acad Sci USA
.
2010
;
107
(
36
):
15792
15797
.

58.

Saravanamuthu
SS
,
Gao
CY
,
Zelenka
PS
.
Notch signaling is required for lateral induction of Jagged1 during FGF-induced lens fiber differentiation
.
Dev Biol
.
2009
;
332
(
1
):
166
176
.

59.

Manderfield
LJ
,
High
FA
,
Engleka
KA
,
Liu
F
,
Li
L
,
Rentschler
S
,
Epstein
JA
.
Notch activation of Jagged1 contributes to the assembly of the arterial wall
.
Circulation
.
2012
;
125
(
2
):
314
323
.

60.

Hernandez
F
,
Peluffo
MC
,
Stouffer
RL
,
Irusta
G
,
Tesone
M
.
Role of the DLL4-NOTCH system in PGF2alpha-induced luteolysis in the pregnant rat
.
Biol Reprod
.
2011
;
84
(
5
):
859
865
.

61.

Accialini
P
,
Hernández
SF
,
Bas
D
,
Pazos
MC
,
Irusta
G
,
Abramovich
D
,
Tesone
M
.
A link between Notch and progesterone maintains the functionality of the rat corpus luteum
.
Reproduction
.
2015
;
149
(
1
):
1
10
.

62.

Wang
J
,
Liu
S
,
Peng
L
,
Dong
Q
,
Bao
R
,
Lv
Q
,
Tang
M
,
Hu
C
,
Li
G
,
Liang
S
,
Zhang
C
.
Notch signaling pathway regulates progesterone secretion in murine luteal cells
.
Reprod Sci
.
2015
;
22
(
10
):
1243
1251
.

63.

Nakamura
M
,
Fukami
M
,
Sugawa
F
,
Miyado
M
,
Nonomura
K
,
Ogata
T
.
Mamld1 knockdown reduces testosterone production and Cyp17a1 expression in mouse Leydig tumor cells
.
PLoS ONE
.
2011
;
6
(
4
):
e19123
.

64.

Stocco
C
,
Telleria
C
,
Gibori
G
.
The molecular control of corpus luteum formation, function, and regression
.
Endocr Rev
.
2007
;
28
(
1
):
117
149
.

65.

Johnston
MJ
,
Bar-Cohen
S
,
Paroush
Z
,
Nystul
TG
.
Phosphorylated Groucho delays differentiation in the follicle stem cell lineage by providing a molecular memory of EGFR signaling in the niche
.
Development
.
2016
;
143
(
24
):
4631
4642
.

66.

Garcia
TX
,
Hofmann
M-C
.
NOTCH signaling in Sertoli cells regulates gonocyte fate
.
Cell Cycle
.
2013
;
12
(
16
):
2538
2545
.

67.

Kondoh
K
,
Sunadome
K
,
Nishida
E
.
Notch signaling suppresses p38 MAPK activity via induction of MKP-1 in myogenesis
.
J Biol Chem
.
2007
;
282
(
5
):
3058
3065
.